Delivery Order SPE2DR25D7061-SPE2DR26F7WSD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed-price contract valued at $4,431.07, with an ultimate completion date of October 31, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency awarded a $12,063.51 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall 10 mg tablets (100-count units), with an ultimate completion date of December 8, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,048.85 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 30 mg tablets (100 count units) with a ceiling value of $6,187.04. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) under a firm fixed-price contract valued at $8,773.53, with an ultimate completion date of December 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $4,633.50 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract. The award was made on December 22, 2025, with an ultimate completion date of December 23, 2025, and represents a non-set-aside, competitively awarded contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,423.64 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets in quantities of 100 units. This firm fixed-price delivery order, awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location for this order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units under a firm fixed-price contract valued at $1,225.66. This non-set-aside competitive award is scheduled for completion by December 2, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 5 mg tablets (100-count units) with a ceiling value of $1,225.66. This non-set-aside, competitively awarded delivery order reflects a firm fixed-price contract type with an ultimate completion date of November 14, 2025. The award was issued on November 13, 2025, and represents a specific fulfillment request under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,793.21 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a firm fixed price and a completion deadline of August 26, 2025. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a $999.999 billion potential value through...
- SPE2DR25D7061Indefinite Delivery Contract
- SPE2DR25D7061-SPE2DR26F7WSDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract valued at $23,466.37, with an ultimate completion date of December 9, 2025. This competitively awarded, non-set-aside delivery order supports the federal government's pharmaceutical supply needs for military and related healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, AmerisourceBergen supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The company's role in the DLA's pharmaceutical supply chain demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 12/7/25 |